TY - GEN AB - This, the second of two volumes on personalized medicine in lung cancer, touches upon the recent progress in targeted drug development based on genomics; emerging biomarkers and therapeutic targets such as EMT, cancer stem cells, and the tumor microenvironment; current personalized clinical management and radiation therapy for lung cancers; and the promise of epigenetics and next-generation sequencing for the advancements towards personalized therapy of lung cancer patients. With chapters on state-of-the-art therapies and technologies written by leading experts working to develop novel companion diagnosis tools for the personalized treatment of lung cancer patients, this volume brings readers up-to-date by presenting the current knowledge on the efforts to make personalized management of lung cancer patients a reality. AU - Ahmad, Aamir. AU - Gadgeel, Shirish M. CN - RC280.L8 CY - Cham : DA - ©2016. DO - 10.1007/978-3-319-24932-2 DO - doi ID - 753156 KW - Lungs LK - https://univsouthin.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-3-319-24932-2 N1 - Includes index. N2 - This, the second of two volumes on personalized medicine in lung cancer, touches upon the recent progress in targeted drug development based on genomics; emerging biomarkers and therapeutic targets such as EMT, cancer stem cells, and the tumor microenvironment; current personalized clinical management and radiation therapy for lung cancers; and the promise of epigenetics and next-generation sequencing for the advancements towards personalized therapy of lung cancer patients. With chapters on state-of-the-art therapies and technologies written by leading experts working to develop novel companion diagnosis tools for the personalized treatment of lung cancer patients, this volume brings readers up-to-date by presenting the current knowledge on the efforts to make personalized management of lung cancer patients a reality. PB - Springer, PP - Cham : PY - ©2016. SN - 9783319249322 SN - 3319249320 T1 - Lung cancer and personalized medicinenovel therapies and clinical management / TI - Lung cancer and personalized medicinenovel therapies and clinical management / UR - https://univsouthin.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-3-319-24932-2 VL - v. 890 ER -